TRPV1 and acute lymphoblastic leukemia: The activation of TRPV1 channels by resiniferatoxin (RTX), a potent analogue of CPS and a TRPV agonist, at 5 μM, arrests the cell cycle at G0/G1 phase, reduces cell proliferation, and induces apoptosis in both Jurkat cells and cell-derived T-ALL patients.